Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Notes Payables (2016 - 2017)

Bio-Techne (TECH) has 4 years of Notes Payables data on record, last reported at $14.6 million in Q1 2017.

  • For Q1 2017, Notes Payables rose 282.83% year-over-year to $14.6 million; the TTM value through Mar 2017 reached $14.6 million, up 282.83%, while the annual FY2016 figure was $3.8 million, 6.59% down from the prior year.
  • Notes Payables reached $14.6 million in Q1 2017 per TECH's latest filing, up from $3.6 million in the prior quarter.
  • Across five years, Notes Payables topped out at $14.6 million in Q1 2017 and bottomed at $3.0 million in Q1 2015.
  • Average Notes Payables over 4 years is $5.2 million, with a median of $3.8 million recorded in 2015.
  • Peak YoY movement for Notes Payables: crashed 36.67% in 2015, then skyrocketed 282.83% in 2017.
  • A 4-year view of Notes Payables shows it stood at $6.0 million in 2014, then plummeted by 36.67% to $3.8 million in 2015, then fell by 5.12% to $3.6 million in 2016, then surged by 305.51% to $14.6 million in 2017.
  • Per Business Quant database, its latest 3 readings for Notes Payables were $14.6 million in Q1 2017, $3.6 million in Q4 2016, and $3.7 million in Q3 2016.